Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction

被引：0
作者：
J D Brioni
M Nakane
G C Hsieh
R B Moreland
T Kolasa
J P Sullivan
机构：
[1] Neuroscience Research,
[2] Global Pharmaceutical Research and Development,undefined
[3] Abbott Laboratories,undefined
来源：
International Journal of Impotence Research | 2002年 / 14卷
关键词：
guanylate cyclase; YC-1; penile erection; erectile dysfunction; corpus cavernosum; sildenafil; cGMP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Soluble guanylate cyclase (sGC) is an important enzyme in corpus cavernosum smooth muscle cells as it is one of the regulators of the synthesis of cGMP. The efficacy of sildenafil (Viagra™) in the treatment of male erectile dysfunction indicates the importance of the cGMP system in the erectile response as the increased levels of cGMP induce relaxation of the corpus cavernosum. sGC is physiologically activated by nitric oxide (NO) during sexual stimulation, and its activity can be pharmacologically enhanced by several NO-donors. Agents like YC-1 can also activate sGC after binding to a novel allosteric site in the enzyme, a site different from the NO binding site. YC-1 can relax rabbit cavernosal tissue and it facilitates penile erection in vivo. This review summarizes the enzymology, biochemistry and pharmacology of this novel allosteric site and its relevance for the regulation of penile function. This type of sGC activators represent a new class of compounds with a different pharmacological profile in comparison to the classical NO-donors and they could be beneficial for the treatment of male erectile dysfunction.
引用
收藏
页码：8 / 14
页数：6
相关论文
共 114 条
  • [1] Moreland RB(2001)The biochemical and neurologic basis for the treatment of male erectile dysfunction. J Pharmacol Exp Therap 296 225-234.
  • [2] Hsieh G(1988)Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem Biophys Res Commun 157 1139-1147.
  • [3] Nakane M(1990)Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265 16841-16845.
  • [4] Brioni JD(1990)A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry 29 10872-10878.
  • [5] Nakane Metal(1997)The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J Clin Invest 100 1488-1492.
  • [6] Nakane Metal(1991)Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Lett 292 217-222.
  • [7] Yuen PS(1992)Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett 304 83-88.
  • [8] Potter LR(1998)Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem J 335 51-57.
  • [9] Garbers DL(2000)The beta(2) subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma. Biochem Biophys Res Commun 271 64-69.
  • [10] Gupta G(2001)Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. J Urol 165 223.-7241.
12345678910